Previous research also revealed that miR-455 inhibited the aggressive behaviors of colorectal cancer cells by down-regulating RAF1, suggesting the potential therapeutic significance of miR-455/RAF1 signaling in the treatment of colorectal carcinoma [30]. This evidence concerns the gene RAF1 and colorectal carcinoma.